PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 38 filers reported holding PROTARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $714,112 | -30.1% | 427,612 | 0.0% | 0.00% | – |
| Q2 2023 | $1,021,993 | -23.6% | 427,612 | 0.0% | 0.00% | – |
| Q1 2023 | $1,338,426 | +16.8% | 427,612 | 0.0% | 0.00% | – |
| Q4 2022 | $1,146,000 | -9.4% | 427,612 | +0.1% | 0.00% | – |
| Q3 2022 | $1,265,000 | +1.0% | 427,388 | -0.0% | 0.00% | – |
| Q2 2022 | $1,253,000 | -42.6% | 427,404 | 0.0% | 0.00% | – |
| Q1 2022 | $2,184,000 | -25.7% | 427,404 | -1.8% | 0.00% | – |
| Q4 2021 | $2,938,000 | -2.6% | 435,251 | -0.1% | 0.00% | – |
| Q3 2021 | $3,015,000 | -29.2% | 435,813 | -0.3% | 0.00% | – |
| Q2 2021 | $4,258,000 | -40.7% | 437,108 | -4.3% | 0.00% | – |
| Q1 2021 | $7,186,000 | +83.4% | 456,533 | +182.0% | 0.00% | – |
| Q4 2020 | $3,919,000 | +1091.2% | 161,899 | +729.1% | 0.00% | – |
| Q3 2020 | $329,000 | -35.5% | 19,526 | +12.1% | 0.00% | – |
| Q2 2020 | $510,000 | – | 17,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $8,077,883 | 2.42% |
| Privium Fund Management (UK) Ltd | 119,730 | $401,096 | 0.32% |
| Ikarian Capital, LLC | 188,664 | $584,859 | 0.13% |
| Orbimed Advisors | 793,558 | $2,483,837 | 0.05% |
| Boxer Capital, LLC | 209,227 | $655 | 0.03% |
| Perceptive Advisors | 290,051 | $907,860 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $198,400 | 0.01% |
| Baker Brothers Advisors | 199,671 | $624,970 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $59,044 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 35,745 | $111,882 | 0.00% |